CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $322,000 | -23.0% | 72,135 | +0.0% | 0.00% | -25.0% |
| Q2 2021 | $418,000 | -10.7% | 72,110 | +8.1% | 0.00% | 0.0% |
| Q1 2021 | $468,000 | -29.0% | 66,712 | -51.4% | 0.00% | -42.9% |
| Q4 2020 | $659,000 | +43.0% | 137,300 | +73.6% | 0.01% | +16.7% |
| Q3 2020 | $461,000 | -1.9% | 79,100 | +13.5% | 0.01% | 0.0% |
| Q2 2020 | $470,000 | +162.6% | 69,700 | +148.0% | 0.01% | +100.0% |
| Q1 2020 | $179,000 | – | 28,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |